CAS NO. |
Products Name |
21102-95-4 |
BMY7378 |
more... |
BMY 7378 is a multi-targeted inhibitor of α2C-adrenoceptor and α1D-adrenoceptor with pKi of 6.54 and 8.2, respectively, and acts as a mixed agonist and antagonist for 5-HT1A receptor with pKi of 8.3. |
|
1402601-82-4 |
TUG-770 |
more... |
TUG-770 is a highly potent free fatty acid receptor 1 (FFA1/GPR40) agonist for treatment of type 2 diabetes. |
|
|
1226895-20-0 |
ABT-346 |
more... |
ATB-346 is a novel hydrogen sulphide-releasing derivative of naproxen with markedly reduced toxicity. |
|
931706-15-9 |
PPQ-102 |
more... |
PPQ-102 is a potent CFTR inhibitor which can completely inhibited CFTR chloride current with IC 50approximately 90 nM. |
|
|
521937-07-5 |
CID755673 |
more... |
CID755673 is a potent and selective cell-active small molecule inhibitor for PKD with an IC50 of 182 nM; exhibits selective PKD1 inhibition when compared with AKT, PLK1, CAK, CAMKIIα, and PKC isoforms. |
|
|
639052-78-1 |
LH-846 |
more... |
LH-846 is a selective inhibitor of casein kinase (CK) 1δ (IC50 values are 290 nM, 1.3 uM and 2.5 uM for CK1δ, ε and α); displays no inhibitory activity at CK2. |
|
|
861393-28-4 |
A-740003 |
more... |
A-740003 is potent, selective and competitive P2X7 receptor antagonist (IC50 values are 18 and 40 nM for rat and human receptors respectively). |
|
1355326-35-0 |
AGI-5198 |
more... |
AGI-5198 is the first highly potent and selective inhibitor of IDH1 R132H/R132C mutants with IC50 of 0.07 μM/0.16 μM. |
|